Infectious Diseases Archive — Page 11 of 13

Open orange prescription bottle lying on its side with numerous green-and-white capsules spilled onto a white surface.
April 25, 2019

A new antibiotic’s mechanism of action

Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.

bacteria microbiome
April 11, 2019

How bugs overcome host defenses

Vanderbilt researchers led by Eric Skaar are probing the mechanisms bacteria use when faced with nutrient starvation — a host defense strategy called “nutritional immunity.”

Portrait of a gray-haired man wearing a dark suit, white shirt, and blue tie.
December 6, 2018

Schaffner honored by Infectious Diseases Society of America

William Schaffner, MD, professor of Preventive Medicine in the Department of Health Policy and professor of Medicine in the Division of Infectious Diseases, is the recipient of the 2018 D.A. Henderson Award for Outstanding Contributions to Public Health.

Two researchers in white lab coats stand in a biomedical laboratory surrounded by equipment and workstations.
July 19, 2018

Team finds potent antibodies against three Ebola viruses

Researchers at Vanderbilt University Medical Center and their colleagues are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans.

Five researchers pose in a laboratory beside a microscope and shelves of scientific supplies. From left: Kevin Niswender, R. Stokes Peebles, Tina Hartert, Lisa Bastarache, and Melissa Bloodworth.
July 12, 2018

Team explores diabetes drug’s ability to treat RSV infection

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

Close-up of pale, branching bacterial colonies growing across a red agar plate.
June 28, 2018

New staph virulence factor

Jun. 28, 2018—The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections.